Literature DB >> 26515424

Biosynthesis of the Peptide Antibiotic Feglymycin by a Linear Nonribosomal Peptide Synthetase Mechanism.

Melanie Gonsior1, Agnes Mühlenweg1, Marcel Tietzmann1, Saskia Rausch1, Annette Poch1, Roderich D Süssmuth2.   

Abstract

Feglymycin, a peptide antibiotic produced by Streptomyces sp. DSM 11171, consists mostly of nonproteinogenic phenylglycine-type amino acids. It possesses antibacterial activity against methicillin-resistant Staphylococcus aureus strains and antiviral activity against HIV. Inhibition of the early steps of bacterial peptidoglycan synthesis indicated a mode of action different from those of other peptide antibiotics. Here we describe the identification and assignment of the feglymycin (feg) biosynthesis gene cluster, which codes for a 13-module nonribosomal peptide synthetase (NRPS) system. Inactivation of an NRPS gene and supplementation of a hydroxymandelate oxidase mutant with the amino acid l-Hpg proved the identity of the feg cluster. Feeding of Hpg-related unnatural amino acids was not successful. This characterization of the feg cluster is an important step to understanding the biosynthesis of this potent antibacterial peptide.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  antibiotics; cell-wall biosynthesis inhibitor; dihydroxyphenylglycine; hydroxyphenylglycine; nonribosomal peptide synthesis; peptides

Mesh:

Substances:

Year:  2015        PMID: 26515424     DOI: 10.1002/cbic.201500432

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  5 in total

Review 1.  Teicoplanin biosynthesis: unraveling the interplay of structural, regulatory, and resistance genes.

Authors:  Oleksandr Yushchuk; Bohdan Ostash; Andrew W Truman; Flavia Marinelli; Victor Fedorenko
Journal:  Appl Microbiol Biotechnol       Date:  2020-02-19       Impact factor: 5.560

2.  Evolution-guided discovery of antibiotics that inhibit peptidoglycan remodelling.

Authors:  Elizabeth J Culp; Nicholas Waglechner; Wenliang Wang; Aline A Fiebig-Comyn; Yen-Pang Hsu; Kalinka Koteva; David Sychantha; Brian K Coombes; Michael S Van Nieuwenhze; Yves V Brun; Gerard D Wright
Journal:  Nature       Date:  2020-02-12       Impact factor: 49.962

3.  A Two-Component regulatory system with opposite effects on glycopeptide antibiotic biosynthesis and resistance.

Authors:  Rosa Alduina; Arianna Tocchetti; Salvatore Costa; Clelia Ferraro; Patrizia Cancemi; Margherita Sosio; Stefano Donadio
Journal:  Sci Rep       Date:  2020-04-10       Impact factor: 4.379

4.  Comparative Genomics and Metabolomics Analyses of Clavulanic Acid-Producing Streptomyces Species Provides Insight Into Specialized Metabolism.

Authors:  Nader F AbuSara; Brandon M Piercey; Marcus A Moore; Arshad Ali Shaikh; Louis-Félix Nothias; Santosh K Srivastava; Pablo Cruz-Morales; Pieter C Dorrestein; Francisco Barona-Gómez; Kapil Tahlan
Journal:  Front Microbiol       Date:  2019-11-08       Impact factor: 5.640

5.  Genomic Insights into the Distribution and Phylogeny of Glycopeptide Resistance Determinants within the Actinobacteria Phylum.

Authors:  Andrés Andreo-Vidal; Elisa Binda; Victor Fedorenko; Flavia Marinelli; Oleksandr Yushchuk
Journal:  Antibiotics (Basel)       Date:  2021-12-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.